Coromandel International Waardering
Is COROMANDEL ondergewaardeerd ten opzichte van de reële waarde, de prognoses van analisten en de prijs ten opzichte van de markt?
Waarderingsscore
2/6Waarderingsscore 2/6
Onder de reële waarde
Aanzienlijk onder de reële waarde
Price-To-Earnings versus peers
Price-To-Earnings versus industrie
Price-To-Earnings versus eerlijke verhouding
Analistenprognose
Aandelenprijs vs Reële waarde
Wat is de reële prijs van COROMANDEL als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.
Onder de reële waarde: COROMANDEL (₹1634.55) is trading above our estimate of fair value (₹780.05)
Aanzienlijk onder de reële waarde: COROMANDEL is trading above our estimate of fair value.
Belangrijkste waarderingsmaatstaf
Welke metriek kun je het beste gebruiken als je kijkt naar de relatieve waardering voor COROMANDEL?
Andere financiële maatstaven die nuttig kunnen zijn voor relatieve waardering.
Wat is COROMANDEL's n/a Ratio? | |
---|---|
n.v.t. | 0x |
n/a | n/a |
Marktkapitalisatie | ₹498.29b |
Belangrijkste statistieken | |
---|---|
Bedrijfswaarde/inkomsten | 2.2x |
Bedrijfswaarde/EBITDA | 22.1x |
PEG-verhouding | 1.5x |
Prijs ten opzichte van winst Verhouding vs gelijken
Hoe verhoudt COROMANDEL's PE Ratio zich tot zijn concurrenten?
Bedrijf | Voorwaarts PE | Geschatte groei | Marktkapitalisatie |
---|---|---|---|
Gemiddelde | 38.9x | ||
506285 Bayer CropScience | 45.4x | 17.1% | ₹299.1b |
523642 PI Industries | 38.7x | 9.1% | ₹682.6b |
SUMICHEM Sumitomo Chemical India | 57.9x | 18.8% | ₹284.8b |
CHAMBLFERT Chambal Fertilisers and Chemicals | 13.8x | 7.1% | ₹194.0b |
COROMANDEL Coromandel International | 35.2x | 23.4% | ₹498.3b |
Price-To-Earnings versus peers: COROMANDEL is good value based on its Price-To-Earnings Ratio (35.2x) compared to the peer average (38.9x).
Prijs ten opzichte van winst Verhouding vs Industrie
Hoe verhoudt COROMANDEL's PE Ratio zich tot andere bedrijven in de IN Chemicals industrie?
Price-To-Earnings versus industrie: COROMANDEL is expensive based on its Price-To-Earnings Ratio (35.2x) compared to the Indian Chemicals industry average (34.2x).
Prijs ten opzichte van winst Ratio vs Eerlijke Ratio
Wat is COROMANDEL's PE Ratio vergeleken met zijn Eerlijke PE Ratio? Dit is de verwachte PE Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.
Eerlijke verhouding | |
---|---|
Huidige PE Ratio | 35.2x |
Eerlijke PE Verhouding | 36.1x |
Price-To-Earnings versus eerlijke verhouding: COROMANDEL is good value based on its Price-To-Earnings Ratio (35.2x) compared to the estimated Fair Price-To-Earnings Ratio (36.1x).
Koersdoelen analisten
Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?
Datum | Prijs aandeel | Gemiddeld 1Y Koersdoel | Verspreiding | Hoog | Laag | 1J Werkelijke prijs | Analisten |
---|---|---|---|---|---|---|---|
Huidige | ₹1,634.55 | ₹1,776.40 +8.7% | 14.5% | ₹2,170.00 | ₹1,300.00 | n/a | 10 |
Oct ’25 | ₹1,728.00 | ₹1,763.00 +2.0% | 14.0% | ₹1,970.00 | ₹1,275.00 | n/a | 10 |
Sep ’25 | ₹1,758.25 | ₹1,763.00 +0.3% | 14.0% | ₹1,970.00 | ₹1,275.00 | n/a | 10 |
Aug ’25 | ₹1,633.70 | ₹1,387.33 -15.1% | 15.2% | ₹1,810.00 | ₹1,125.00 | n/a | 9 |
Jul ’25 | ₹1,597.20 | ₹1,344.70 -15.8% | 10.7% | ₹1,670.00 | ₹1,125.00 | n/a | 10 |
Jun ’25 | ₹1,307.30 | ₹1,295.70 -0.9% | 8.9% | ₹1,400.00 | ₹1,025.00 | n/a | 10 |
May ’25 | ₹1,207.85 | ₹1,262.60 +4.5% | 8.7% | ₹1,400.00 | ₹1,025.00 | n/a | 10 |
Apr ’25 | ₹1,114.45 | ₹1,198.40 +7.5% | 8.2% | ₹1,340.00 | ₹1,015.00 | n/a | 10 |
Mar ’25 | ₹1,087.45 | ₹1,198.40 +10.2% | 8.2% | ₹1,340.00 | ₹1,015.00 | n/a | 10 |
Feb ’25 | ₹1,070.50 | ₹1,223.40 +14.3% | 9.6% | ₹1,430.00 | ₹1,015.00 | n/a | 10 |
Jan ’25 | ₹1,247.65 | ₹1,258.45 +0.9% | 8.7% | ₹1,430.00 | ₹1,000.00 | n/a | 11 |
Dec ’24 | ₹1,169.60 | ₹1,239.55 +6.0% | 7.7% | ₹1,390.00 | ₹1,000.00 | n/a | 11 |
Nov ’24 | ₹1,048.95 | ₹1,233.60 +17.6% | 8.0% | ₹1,390.00 | ₹1,000.00 | ₹1,691.80 | 10 |
Oct ’24 | ₹1,146.30 | ₹1,204.80 +5.1% | 6.6% | ₹1,360.00 | ₹1,075.00 | ₹1,728.00 | 10 |
Sep ’24 | ₹1,111.00 | ₹1,204.80 +8.4% | 6.6% | ₹1,360.00 | ₹1,075.00 | ₹1,758.25 | 10 |
Aug ’24 | ₹1,043.40 | ₹1,204.80 +15.5% | 6.6% | ₹1,360.00 | ₹1,075.00 | ₹1,633.70 | 10 |
Jul ’24 | ₹948.40 | ₹1,205.13 +27.1% | 7.3% | ₹1,360.00 | ₹1,065.00 | ₹1,597.20 | 8 |
Jun ’24 | ₹946.65 | ₹1,179.80 +24.6% | 8.0% | ₹1,360.00 | ₹1,058.00 | ₹1,307.30 | 10 |
May ’24 | ₹942.45 | ₹1,173.00 +24.5% | 8.8% | ₹1,350.00 | ₹1,050.00 | ₹1,207.85 | 10 |
Apr ’24 | ₹879.25 | ₹1,164.00 +32.4% | 7.9% | ₹1,350.00 | ₹1,050.00 | ₹1,114.45 | 10 |
Mar ’24 | ₹913.10 | ₹1,163.18 +27.4% | 7.5% | ₹1,350.00 | ₹1,050.00 | ₹1,087.45 | 11 |
Feb ’24 | ₹900.45 | ₹1,158.18 +28.6% | 6.9% | ₹1,323.00 | ₹1,045.00 | ₹1,070.50 | 11 |
Jan ’24 | ₹887.15 | ₹1,150.00 +29.6% | 6.1% | ₹1,323.00 | ₹1,058.00 | ₹1,247.65 | 10 |
Dec ’23 | ₹918.50 | ₹1,150.00 +25.2% | 6.1% | ₹1,323.00 | ₹1,058.00 | ₹1,169.60 | 10 |
Nov ’23 | ₹964.00 | ₹1,154.89 +19.8% | 8.0% | ₹1,250.00 | ₹972.00 | ₹1,048.95 | 9 |
Analistenprognose: Target price is less than 20% higher than the current share price.